Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice
Crossref DOI link: https://doi.org/10.1007/s12272-015-0621-8
Published Online: 2015-10-08
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tahara, Atsuo
Takasu, Toshiyuki
Yokono, Masanori
Imamura, Masakazu
Kurosaki, Eiji
Text and Data Mining valid from 2015-10-08